A fast and simple approach for the simultaneous detection of hematopoietic chimerism, NPM1, and FLT3-ITD mutations after allogeneic stem cell transplantation-Reference-Cited by-同舟云学术

A fast and simple approach for the simultaneous detection of hematopoietic chimerism, NPM1, and FLT3-ITD mutations after allogeneic stem cell transplantation

Published:2013-08-02 Issue:2 Volume:93 Page:293-298
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Waterhouse Miguel,Bertz Hartmut,Finke Juergen

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-013-1858-2.pdf

Reference22 articles.

1. Serrano J, Roman J, Herrera C, Castillejo JA, Reina ML, Gonzalez MG, Rodriguez MC, Pascual A, Sanchez J, Torres A (1999) Increasing hematopoietic mixed chimerism alter BMT with total depletion of CD4+ and partial depletion of CD8+ lymphocytes is associated with a higher incidence of relapse. Bone Marrow Transplant 23:475–482

2. Bader P, Beck J, Frey A, Schlegel PG, Hebarth H, Handgretinger R, Einsele H, Niemeyer C, Benda N, Faul C, Kanz L, Niethammer D, Klingebiel T (1998) Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant 21:487–495

3. Schaap N, Schattenberg A, Mensink E, Prejiers F, Hillegers M, Knops R, Pennings A, Boezeman J, Geurts van Kessel A, de Pauw B, de Witte T (2002) Long-term follow up of persisting mixed chimerism after partially T cell depleted allogeneic stem cell transplantation. Leukemia 16:13–21

4. Dey BR, McAfee S, Colby C, Sackestein R, Saidman S, Tarbell N, Sachs DH, Sykes M, Spitzer TR (2003) Impact or prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation. Biol Blood Marrow Transplant 9(5):320–329

5. Zeiser R, Spyridonidis A, Wäsch R, Ihorst G, Grüllich C, Bertz H, Finke J (2005) Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation. Leukemia 19:814–821

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of chimerism and immunomodulation to prevent post-transplantation relapse in childhood acute myeloblastic leukemia: is it the right approach?;Pediatric Hematology and Oncology;2020-02-06

2. Cell-free DNA characteristics and chimerism analysis in patients after allogeneic cell transplantation;Clinical Biochemistry;2018-02

3. Reinventing Diagnosis;Precision Medicine and the Reinvention of Human Disease;2018

4. Simultaneous detection of mutations and copy number variation of NPM1 in the acute myeloid leukemia using multiplex ligation-dependent probe amplification;Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis;2016-04

5. Mixed chimerism in haemoglobinopathies: from risk of graft rejection to immune tolerance;Tissue Antigens;2014-02-20